Reversal of Remimazolam by a Single Dose of Flumazenil

NACompletedINTERVENTIONAL
Enrollment

224

Participants

Timeline

Start Date

August 2, 2022

Primary Completion Date

May 10, 2023

Study Completion Date

May 13, 2023

Conditions
Flumazenil Adverse ReactionAmbulatory SurgeryPostoperative NauseaRemimazolam
Interventions
DRUG

Flumazenil

During the procedure, continuous infusion of remimazolam dose of 2mg/kg/hr. when procedure ends, infusion remimazolam stops and 0.9% normal saline or 0.2mg of flumazenil according to allocated groups.

Trial Locations (1)

05030

Konkuk University Medical Center, Seoul

All Listed Sponsors
lead

Konkuk University Medical Center

OTHER